KDMF (Korea Drug Master File) Approved Products & Companies

  • Product:

    Amlodipine mesylate

  • Initial Registration:

    2011-08-19

  • Registration Number:

    20101029-130-H-16-04(2)

  • MFDS Classification:

    etc

  • Applicant:

    New One Science Co., Ltd.

  • Last Modified:

    2021-02-26

  • Country:

    India

  • Status:

    Active

  • Manufacturer:

    Cipla Limited

  • Withdrawal Date:

  • Final Annual Reporting Year:

    2012

  • Manufacturing Facility:

    Virgonagar Post, Old Madras Road, Bangalore 560 049, INDIA

  • Product:

    Clazocentan disodium

  • Initial Registration:

    2023-12-07

  • Registration Number:

    Su5734-1-ND

  • MFDS Classification:

    new substance

  • Applicant:

    Nexera Pharma Korea Co., Ltd.

  • Last Modified:

    2024-05-31

  • Country:

    Swiss

  • Status:

    Active

  • Manufacturer:

    Carbogen Amcis AG

  • Withdrawal Date:

  • Final Annual Reporting Year:

  • Manufacturing Facility:

    Gebaude 171, 173 and 177, Hauptstrasse 171 Bubendorf, 4416, Switzerland

  • Product:

    Dexibuprofen

  • Initial Registration:

    2013-04-18

  • Registration Number:

    20120406-145-I-37-02(15)

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Nexpharm Korea Co., Ltd.

  • Last Modified:

  • Country:

    china

  • Status:

    Active

  • Manufacturer:

    Hubei Biocause Heilen Pharmaceutical Co., Ltd

  • Withdrawal Date:

  • Final Annual Reporting Year:

  • Manufacturing Facility:

    122 Yangwan Road, Jingmen City, Hubei Province, 448000, PR China

  • Product:

    trimebutine maleate

  • Initial Registration:

    2020-11-05

  • Registration Number:

    20180130-13-B-404-13(22)

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Nexus Co., Ltd.

  • Last Modified:

    2023-10-17

  • Country:

    china

  • Status:

    Withdrawal

  • Manufacturer:

    Zhejiang East-Asia Pharmaceutical Co., Ltd. Ltd.

  • Withdrawal Date:

    2023-10-17

  • Final Annual Reporting Year:

  • Manufacturing Facility:

    Coastal Industrial City, Pubagang town, Sanmen county, Zhejiang, PRChina

  • Product:

    Leuprorelin acetate

  • Initial Registration:

    2022-06-10

  • Registration Number:

    20220610-210-J-1313

  • MFDS Classification:

    Appendix 1

  • Applicant:

    NIBEC Co., Ltd.

  • Last Modified:

  • Country:

    korea

  • Status:

    Active

  • Manufacturer:

    NIBEC Co., Ltd.

  • Withdrawal Date:

  • Final Annual Reporting Year:

  • Manufacturing Facility:

    116 Bamdi-gil, Iwol-myeon, Jincheon-gun, Chungcheongbuk-do

  • Product:

    Heparin sodium

  • Initial Registration:

    2013-08-23

  • Registration Number:

    20100211-124-G-17-01(10)

  • MFDS Classification:

    Appendix 1

  • Applicant:

    NM Pharmaceutical Co., Ltd.

  • Last Modified:

  • Country:

    china

  • Status:

    Active

  • Manufacturer:

    Yantai Dongcheng Biochemicals Co., Ltd.

  • Withdrawal Date:

  • Final Annual Reporting Year:

    2024

  • Manufacturing Facility:

    No. 7, Changbaishan Road, Yantai Development Zone, Shandong Province, PR China.

  • Product:

    Memantine hydrochloride

  • Initial Registration:

    2022-07-26

  • Registration Number:

    20210518-209-J-917(1)

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Northeast Farm Korea Co., Ltd.

  • Last Modified:

  • Country:

    India

  • Status:

    Active

  • Manufacturer:

    Unichem Laboratories Ltd.

  • Withdrawal Date:

  • Final Annual Reporting Year:

  • Manufacturing Facility:

    Plot No. 197, Sector-1, Pithampur, Dist. Dhar (M.P.), India

  • Product:

    Remifentanil hydrochloride

  • Initial Registration:

    2014-09-02

  • Registration Number:

    Number 5-1-ND(2)

  • MFDS Classification:

    new substance

  • Applicant:

    Nosa Chemical Co., Ltd.

  • Last Modified:

    2020-04-09

  • Country:

    uk

  • Status:

    Active

  • Manufacturer:

    Macfarlan Smith Ltd.

  • Withdrawal Date:

  • Final Annual Reporting Year:

    2018

  • Manufacturing Facility:

    10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom

  • Product:

    Terbinafine hydrochloride

  • Initial Registration:

    2005-08-31

  • Registration Number:

    20050831-49-A-98-08

  • MFDS Classification:

    Appendix 1

  • Applicant:

    Novartis Korea

  • Last Modified:

    2020-03-17

  • Country:

  • Status:

    Active

  • Manufacturer:

    [Partial Contract Manufacturing (Client)] Novartis Pharma AG@[Partial Contract Manufacturing (Manufacturer)] Novartis Ringaskiddy Ltd@[Partial Contract Manufacturing (Manufacturer)] Novartis Pharma Stein AG

  • Withdrawal Date:

  • Final Annual Reporting Year:

    2022

  • Manufacturing Facility:

    [Partially Contract Manufacturing (Client)] Lichtstrasse 35, 4056 Basel, Switzerland @ [Partially Contract Manufacturing (Manufacturer)] Ringaskiddy Co. Cork Ireland @ [Partially Contract Manufacturing (Manufacturer)] Schaffhauserstrasse 4332 Stein Switzerland

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.